Katharina Gschwandtner

Katharina Gschwandtner is an experienced professional in global program management within the biopharmaceutical industry, currently serving as Director of Global Program Management for the Plasma-Derived Therapies Business Unit at Takeda since January 2019. Previously, Gschwandtner held various positions at Shire, including Associate Director and Global Program Manager in Immunology, and also served as Global Program Manager at Baxalta. Prior experience includes roles at Baxter International Inc., where responsibilities involved managing high-visibility projects, particularly in the vaccine sector, and supporting research initiatives at the Fraunhofer Institute for Cell Therapy and Immunology. Gschwandtner holds a Master of Science in Regulatory Affairs and a Diplom Ingenieur in Medical and Pharmaceutical Biotechnology from the University of Applied Life Sciences in Krems, Austria.